Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
12/29/2009 | US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents |
12/29/2009 | US7638495 inhibiting precipitation; bone morphogenic proteins |
12/29/2009 | CA2429440C Dehalogeno-compounds |
12/29/2009 | CA2339054C E-isomeric fullerene derivatives |
12/29/2009 | CA2282720C Dolastatin-15 derivatives in combination with taxanes |
12/24/2009 | US20090318667 Peptoid compositions and methods of using the same |
12/24/2009 | US20090318368 Angiotensin-converting enzyme inhibitory peptides |
12/24/2009 | US20090318367 Use of SH2 STAT3/STAT1 Peptidomimetics as Anticancer Drugs |
12/24/2009 | US20090318366 Cholesterol lowering protein hydrolysates |
12/24/2009 | US20090317409 Antibodies for ubiquitinated proteins |
12/23/2009 | WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same |
12/23/2009 | WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists |
12/23/2009 | EP1613302B1 Preserved and stable compositions containing peptide copper complexes and methods related thereto |
12/23/2009 | CN101611050A Pharmaceutically acceptable salts of Thymodepressin and processes for their manufacture |
12/23/2009 | CN101611039A HCV NS3 protease inhibitors |
12/23/2009 | CN101608203A Fish skin collagen peptide with moistening effect and preparation process and application thereof |
12/23/2009 | CN101607982A Fish skin collagen peptide with whitening effect and preparation process and application thereof |
12/23/2009 | CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists |
12/23/2009 | CA2726161A1 A peptide derivative and a composition for promoting lacrimal secretion comprising the same |
12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
12/22/2009 | US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease |
12/22/2009 | CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/22/2009 | CA2487306C Novel piperidine compound |
12/22/2009 | CA2276267C Peptide-lipid conjugates, liposomes and liposomal drug delivery |
12/17/2009 | WO2009151708A2 Peptide analogs of alpha-melanocyte stimulating hormone |
12/17/2009 | WO2009151520A2 Biocompatible and biodegradable elastomeric polymers |
12/17/2009 | WO2009149880A1 Lactobacillus helveticus strains for producing hypotensive peptides |
12/17/2009 | WO2009117539A3 Bioluminescent construct |
12/17/2009 | US20090312540 Spatially-defined macrocycles incorporating peptide bond surrogates |
12/17/2009 | US20090312270 Peptides having an ace inhibiting effect |
12/17/2009 | US20090312265 Novel antimicrobial peptides and use thereof |
12/17/2009 | US20090312241 Macrocyclic Compounds as Antiviral Agents |
12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
12/17/2009 | US20090311177 Radiolabelling Methods |
12/17/2009 | CA2726076A1 Peptide analogs of alpha-melanocyte stimulating hormone |
12/17/2009 | CA2725611A1 Lactobacillus helveticus strains for producing hypotensive peptides |
12/17/2009 | CA2723824A1 Biocompatible and biodegradable elastomeric polymers |
12/16/2009 | EP2132220A1 Integrin targeted cyclopeptide ligands, their preparation and use |
12/16/2009 | EP2132219A2 Ace-inhibitory peptides from whey and methods for providing the same. |
12/16/2009 | CN101605806A Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan |
12/16/2009 | CN101602792A Novel antibacterial lipopeptid and preparation and application thereof |
12/16/2009 | CN101602791A Integrin receptor target lipidosome drug carrier, preparation method and application thereof |
12/16/2009 | CN100569796C Immune modulating peptide |
12/15/2009 | US7632933 Corticotropin releasing factor 2 receptor agonists |
12/15/2009 | US7632919 Polystyrene binding peptides and methods of use |
12/15/2009 | US7632855 5-(5-Chloro-2,4-dihydroxy-phenyl)-4-(4-methoxy-phenyl)-2H-pyrazole-3-carboxylic acid, for example; for treatment of diseases which are mediated by excessive or inappropriate HSP90 activity, such as cancers |
12/15/2009 | US7632805 Administering a biodrug comprising a growth factor binding compounds having a central non-peptide organic scaffold, such as a calix[4]arene, to which arelinked cyclic tetrapeptides; angiogenesis inhibiters; antitumor agents; solid tumors;anticarciogenic agents; restenosis |
12/15/2009 | US7632646 Tuberculosis diagnostic test |
12/15/2009 | US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc |
12/15/2009 | US7632502 Immunoglobulin for diagnosis and prevention of yeast infections |
12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
12/10/2009 | WO2009148923A1 Hepatitis c virus inhibitors |
12/10/2009 | US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter |
12/10/2009 | US20090306030 Methods Of Inhibiting Osteoclast Activity |
12/10/2009 | US20090305995 Agonists and antagonists of the somatostatin receptor |
12/10/2009 | US20090304869 Peptides Having an Ace Inhibiting Effect |
12/10/2009 | US20090304629 Macrocyclic hepatitis c serine protease inhibitors |
12/10/2009 | US20090304626 Hepatitis C Virus Inhibitors |
12/09/2009 | EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof |
12/09/2009 | EP2130548A2 Growth Hormone Releasing Peptides |
12/09/2009 | EP1963357B1 Compounds for the inhibition of apoptosis |
12/09/2009 | EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
12/09/2009 | CN101600730A Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
12/09/2009 | CN101600728A Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
12/09/2009 | CN101600428A Compounds and compositions as channel activating protease inhibitors |
12/09/2009 | CN101597291A 2-aminoacyl tryptophyl-Beta-tetrahydric carboline-3-carboxylic acid carbobenzoxy as well as preparation method and application thereof |
12/09/2009 | CN101597290A Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof |
12/09/2009 | CN101597289A 2-tryptophanyl-Beta-tetrahydric carboline-3-formyol amino-acid benzyl ester and preparation method and application thereof |
12/09/2009 | CN101597288A 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof |
12/08/2009 | US7629437 Fluorogenic materials and uses thereof |
12/08/2009 | US7629319 inhibiting platelet aggregation; for treatment of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis, cancer, and neurodegenerative disorders |
12/08/2009 | US7629318 Immunosuppressant compounds, methods and uses related thereto |
12/08/2009 | US7629317 Group of Gastric Antrum Mucosal Proteins that are gastrokines, designated AMP-18. AMP-18 genomic DNA, and cDNA molecules was sequenced for human and mouse, and the protein sequences are predicted from the nucleotide sequences; diagnostic and therapeutic agents for gastrointestinal tract |
12/08/2009 | US7628989 Methods of inducing an immune response |
12/08/2009 | CA2296742C Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds |
12/03/2009 | WO2009146347A1 Hepatitis c virus inhibitors |
12/03/2009 | US20090299036 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
12/03/2009 | US20090299033 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules |
12/03/2009 | US20090298919 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
12/03/2009 | US20090298915 Topical drug delivery |
12/03/2009 | US20090298781 Compounds for the inhibition of apoptosis |
12/03/2009 | US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life |
12/03/2009 | US20090297689 Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides |
12/03/2009 | US20090297545 Immunomodulatory dairy peptides and uses thereof |
12/02/2009 | EP2125878A1 Short bio-active peptides for cellular and immunological modulation |
12/02/2009 | EP2125870A1 Inhibitors of hepatitis c ns3 protease |
12/02/2009 | EP2125862A1 Methods for the synthesis of cyclic peptides |
12/02/2009 | EP2125113A2 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
12/02/2009 | CN101595121A Pyrrolydine derivatives as IAP inhibitors |
12/02/2009 | CN101591377A Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof |
12/02/2009 | CN101591376A Oligopeptide with thrombolysis activity, preparation method and application thereof |
12/02/2009 | CN101591375A Compound with analgesic activity, preparation method and application thereof |
12/02/2009 | CN101591348A Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof |
12/02/2009 | CN101591335A N-(L-aminoacyl)-1, 2, 3, 4-tetrahydrochysene carboline acyl aminoacid benzyl ester, synthetic method and application thereof |
12/01/2009 | US7626042 O-substituted hydroxyaryl derivatives |
12/01/2009 | US7626023 Compounds for treating tumors |
12/01/2009 | US7626002 Cytokine zalpha11 ligand antibodies |
12/01/2009 | US7625870 Ala-Glu-Asp-Leu tetrapeptide of sequence 1; no side effects observed during long term administration; nontoxic; bronchitis, emphysema, asthma, COPD |
12/01/2009 | US7625710 Methods for determining 2F1-binding compounds |
11/26/2009 | WO2009141687A1 New optically pure compounds for improved therapeutic efficiency |